HSP70 inhibitor amplifies the bFGF‑induced release of IL‑6 in osteoblasts

Kuroyanagi,Gen; Hioki,Tomoyuki; Matsushima‑Nishiwaki,Rie; Kozawa,Osamu; Tokuda,Haruhiko

doi:10.3892/mmr.2023.13117

HSP70 inhibitor amplifies the bFGF‑induced release of IL‑6 in osteoblasts

Authors:
- Gen Kuroyanagi
- Tomoyuki Hioki
- Rie Matsushima‑Nishiwaki
- Osamu Kozawa
- Haruhiko Tokuda
View Affiliations

Affiliations: Department of Rehabilitation Medicine, Nagoya City University Graduate School of Medical Sciences, Nagoya, Aichi 467‑8601, Japan, Department of Pharmacology, Gifu University Graduate School of Medicine, Gifu 501‑1194, Japan
Published online on: October 24, 2023 https://doi.org/10.3892/mmr.2023.13117
Article Number: 230

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Heat shock protein 70 (HSP70) functions as an ATP‑dependent molecular chaperone under stress and is involved in protein homeostasis, folding and degradation. HSP70 inhibitors amplify TGF‑β‑stimulated VEGF synthesis in the mouse osteoblastic MC3T3‑E1 cell line. Basic fibroblast growth factor (bFGF) stimulates IL‑6 release via p38 MAPK in MC3T3‑E1 osteoblast‑like cells. In the present study, the effects of HSP70 on the bFGF‑stimulated release of IL‑6 was evaluated using MC3T3‑E1 osteoblast‑like cells. IL‑6 release and mRNA expression levels were analyzed using ELISA and reverse transcription‑quantitative PCR, respectively. Phosphorylation of p38 MAPK and HSP70 was assessed using western blotting. HSP70 inhibitor VER‑155008 significantly increased the bFGF‑stimulated release of IL‑6 in both MC3T3‑E1 osteoblastic cells and normal human osteoblasts. Furthermore, VER‑155008 significantly enhanced the mRNA expression levels of IL‑6 stimulated by bFGF. Western blotting demonstrated a significant increase in the bFGF‑stimulated phosphorylation of p38 MAPK in VER‑155008‑treated MC3T3‑E1 cells. A significant increase in the bFGF‑stimulated phosphorylation of p38 MAPK was also demonstrated in MC3T3‑E1 cells treated with YM‑08, another HSP70 inhibitor. VER‑155008 or YM‑08 did not significantly affect the expression of HSP70 with or without bFGF stimulation. Finally, the specific p38 MAPK inhibitor SB203580 markedly suppressed the enhancing effects of VER‑155008 on bFGF‑stimulated release of IL‑6. Taken together, these results indicated that HSP70 inhibitor amplified bFGF‑stimulated release of IL‑6 through p38 MAPK activation in the osteoblastic MC3T3‑E1 cell line.

View Figures

View References

1	Hendrick JP and Hartl FU: Molecular chaperone functions of heat-shock proteins. Annu Rev Biochem. 62:349–384. 1993. View Article : Google Scholar : PubMed/NCBI
2	Hartl FU, Bracher A and Hayer-Hartl M: Molecular chaperones in protein folding and proteostasis. Nature. 475:324–332. 2011. View Article : Google Scholar : PubMed/NCBI
3	Murphy ME: The HSP70 family and cancer. Carcinogenesis. 34:1181–1188. 2013. View Article : Google Scholar : PubMed/NCBI
4	Li C, Sunderic K, Nicoll SB and Wang S: Downregulation of heat shock protein 70 impairs osteogenic and chondrogenic differentiation in human mesenchymal stem cells. Sci Rep. 8:5532018. View Article : Google Scholar : PubMed/NCBI
5	Wang X, Tokuda H, Hatakeyama D, Hirade K, Niwa M, Ito H, Kato K and Kozawa O: Mechanism of simvastatin on induction of heat shock protein in osteoblasts. Arch Biochem Biophys. 415:6–13. 2003. View Article : Google Scholar : PubMed/NCBI
6	Sakai G, Tokuda H, Fujita K, Kainuma S, Kawabata T, Matsushima-Nishiwaki R, Kozawa O and Otsuka T: Heat shock protein 70 negatively regulates TGF-β-stimulated VEGF synthesis via p38 MAP kinase in osteoblasts. Cell Physiol Biochem. 44:1133–1145. 2017. View Article : Google Scholar : PubMed/NCBI
7	Kular J, Tickner J, Chim SM and Xu J: An overview of the regulation of bone remodelling at the cellular level. Clin Biochem. 45:863–873. 2012. View Article : Google Scholar : PubMed/NCBI
8	Kishimoto T, Akira S, Narazaki M and Taga T: Interleukin-6 family of cytokines and gp130. Blood. 86:1243–1254. 1995. View Article : Google Scholar : PubMed/NCBI
9	Sims NA: Cell-specific paracrine actions of IL-6 family cytokines from bone, marrow and muscle that control bone formation and resorption. Int J Biochem Cell Biol. 79:14–23. 2016. View Article : Google Scholar : PubMed/NCBI
10	Prystaz K, Kaiser K, Kovtun A, Haffner-Luntzer M, Fischer V, Rapp AE, Liedert A, Strauss G, Waetzig GH, Rose-John S and Ignatius A: Distinct effects of IL-6 classic and trans-signaling in bone fracture healing. Am J Pathol. 188:474–490. 2018. View Article : Google Scholar : PubMed/NCBI
11	Franchimont N, Wertz S and Malaise M: Interleukin-6: An osteotropic factor influencing bone formation? Bone. 37:601–606. 2005. View Article : Google Scholar : PubMed/NCBI
12	Roodman GD: Perspectives: Interleukin-6: An osteotropic factor? J Bone Miner Res. 7:475–478. 1992. View Article : Google Scholar : PubMed/NCBI
13	Charoenlarp P, Rajendran AK and Iseki S: Role of fibroblast growth factors in bone regeneration. Inflamm Regen. 37:102017. View Article : Google Scholar : PubMed/NCBI
14	Luong LN, Ramaswamy J and Kohn DH: Effects of osteogenic growth factors on bone marrow stromal cell differentiation in a mineral-based delivery system. Biomaterials. 33:283–294. 2012. View Article : Google Scholar : PubMed/NCBI
15	Kozawa O, Suzuki A and Uematsu T: Basic fibroblast growth factor induces interleukin-6 synthesis in osteoblasts: Autoregulation by protein kinase C. Cell Signal. 9:463–468. 1997. View Article : Google Scholar : PubMed/NCBI
16	Kozawa O, Tokuda H, Matsuno H and Uematsu T: Involvement of p38 mitogen-activated protein kinase in basic fibroblast growth factor-induced interleukin-6 synthesis in osteoblasts. J Cell Biochem. 74:479–485. 1999. View Article : Google Scholar : PubMed/NCBI
17	Sudo H, Kodama HA, Amagai Y, Yamamoto S and Kasai S: In vitro differentiation and calcification in a new clonal osteogenic cell line derived from newborn mouse calvaria. J Cell Biol. 96:191–198. 1983. View Article : Google Scholar : PubMed/NCBI
18	Kozawa O, Suzuki A, Tokuda H and Uematsu T: Prostaglandin F2alpha stimulates interleukin-6 synthesis via activation of PKC in osteoblast-like cells. Am J Physiol. 272((2 Pt 1)): E208–E211. 1997.PubMed/NCBI
19	Kondo A, Otsuka T, Matsushima-Nishiwaki R, Kuroyanagi G, Mizutani J, Wada I, Kozawa O and Tokuda H: Inhibition of SAPK/JNK leads to enhanced IL-1-induced IL-6 synthesis in osteoblasts. Arch Biochem Biophys. 535:227–233. 2013. View Article : Google Scholar : PubMed/NCBI
20	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(−Delta Delta C(T)) Method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
21	Laemmli UK: Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 227:680–685. 1970. View Article : Google Scholar : PubMed/NCBI
22	Kato K, Ito H, Hasegawa K, Inaguma Y, Kozawa O and Asano T: Modulation of the stress-induced synthesis of hsp27 and alpha B-crystallin by cyclic AMP in C6 rat glioma cells. J Neurochem. 66:946–950. 1996. View Article : Google Scholar : PubMed/NCBI
23	Kozawa O, Niwa M, Hatakeyama D, Tokuda H, Oiso Y, Matsuno H, Kato K and Uematsu T: Specific induction of heat shock protein 27 by glucocorticoid in osteoblasts. J Cell Biochem. 86:357–364. 2002. View Article : Google Scholar : PubMed/NCBI
24	Schlecht R, Scholz SR, Dahmen H, Wegener A, Sirrenberg C, Musil D, Bomke J, Eggenweiler HM, Mayer MP and Bukau B: Functional analysis of Hsp70 inhibitors. PLoS One. 8:e784432013. View Article : Google Scholar : PubMed/NCBI
25	Miyata Y, Li X, Lee HF, Jinwal UK, Srinivasan SR, Seguin SP, Young ZT, Brodsky JL, Dickey CA, Sun D and Gestwicki JE: Synthesis and initial evaluation of YM-08, a blood-brain barrier permeable derivative of the heat shock protein 70 (Hsp70) inhibitor MKT-077, which reduces tau levels. ACS Chem Neurosci. 4:930–939. 2013. View Article : Google Scholar : PubMed/NCBI
26	Cuenda A, Rouse J, Doza YN, Meier R, Cohen P, Gallagher TF, Young PR and Lee JC: SB203580 is a specific inhibitor of a MAP kinase homologue which is stimulated by cellular stresses and interleukin-1. FEBS Lett. 364:229–233. 1995. View Article : Google Scholar : PubMed/NCBI
27	Thouverey C and Caverzasio J: Focus on the p38 MAPK signaling pathway in bone development and maintenance. Bonekey Rep. 4:7112015. View Article : Google Scholar : PubMed/NCBI
28	Mayer MP and Bukau B: Hsp70 chaperones: Cellular functions and molecular mechanism. Cell Mol Life Sci. 62:670–684. 2005. View Article : Google Scholar : PubMed/NCBI
29	Chen E, Xue D, Zhang W, Lin F and Pan Z: Extracellular heat shock protein 70 promotes osteogenesis of human mesenchymal stem cells through activation of the ERK signaling pathway. FEBS Lett. 589((24 Pt B)): 4088–4096. 2015. View Article : Google Scholar : PubMed/NCBI
30	Zhang W, Xue D, Yin H, Wang S, Li C, Chen E, Hu D, Tao Y, Yu J, Zheng Q, et al: Overexpression of HSPA1A enhances the osteogenic differentiation of bone marrow mesenchymal stem cells via activation of the Wnt/β-catenin signaling pathway. Sci Rep. 6:276222016. View Article : Google Scholar : PubMed/NCBI
31	Kawabata T, Tokuda H, Sakai G, Fujita K, Matsushima-Nishiwaki R, Kuroyanagi G, Otsuka T and Kozawa O: HSP70 inhibitor suppresses IGF-I-stimulated migration of osteoblasts through p44/p42 MAP kinase. Biomedicines. 6:1092018. View Article : Google Scholar : PubMed/NCBI
32	Kawabata T, Otsuka T, Fujita K, Sakai G, Kim W, Matsushima-Nishiwaki R, Kuroyanagi G, Kozawa O and Tokuda H: HSP70 inhibitors reduce the osteoblast migration by epidermal growth factor. Curr Mol Med. 18:486–495. 2018. View Article : Google Scholar : PubMed/NCBI
33	Kuroyanagi G, Tachi J, Fujita K, Kawabata T, Sakai G, Nakashima D, Kim W, Tanabe K, Matsushima-Nishiwaki R, Otsuka T, et al: HSP70 inhibitors upregulate prostaglandin E1-induced synthesis of interleukin-6 in osteoblasts. PLoS One. 17:e02791342022. View Article : Google Scholar : PubMed/NCBI